- Home
- EBS vs GRAL Comparison
EBS vs GRAL Comparison
Compare EBS & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- GRAL
- Stock Information
- Founded
- EBS 1998
- GRAL 2016
- Country
- EBS United States
- GRAL United States
- Employees
- EBS N/A
- GRAL N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- GRAL
- Sector
- EBS Health Care
- GRAL
- Exchange
- EBS Nasdaq
- GRAL NYSE
- Market Cap
- EBS 353.9M
- GRAL 1.3B
- IPO Year
- EBS 2006
- GRAL N/A
- Fundamental
- Price
- EBS $6.61
- GRAL $49.23
- Analyst Decision
- EBS Strong Buy
- GRAL Buy
- Analyst Count
- EBS 3
- GRAL 3
- Target Price
- EBS $14.33
- GRAL $31.50
- AVG Volume (30 Days)
- EBS 1.3M
- GRAL 1.5M
- Earning Date
- EBS 08-05-2025
- GRAL 08-12-2025
- Dividend Yield
- EBS N/A
- GRAL N/A
- EPS Growth
- EBS N/A
- GRAL N/A
- EPS
- EBS N/A
- GRAL N/A
- Revenue
- EBS $965,400,000.00
- GRAL $130,711,000.00
- Revenue This Year
- EBS N/A
- GRAL $19.52
- Revenue Next Year
- EBS $18.88
- GRAL $20.37
- P/E Ratio
- EBS N/A
- GRAL N/A
- Revenue Growth
- EBS N/A
- GRAL 30.47
- 52 Week Low
- EBS $4.02
- GRAL $12.33
- 52 Week High
- EBS $15.10
- GRAL $63.99
- Technical
- Relative Strength Index (RSI)
- EBS 47.87
- GRAL N/A
- Support Level
- EBS $6.22
- GRAL N/A
- Resistance Level
- EBS $6.95
- GRAL N/A
- Average True Range (ATR)
- EBS 0.32
- GRAL 0.00
- MACD
- EBS -0.05
- GRAL 0.00
- Stochastic Oscillator
- EBS 21.81
- GRAL 0.00
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.